Carcinoma initiation via Rb tumor suppressor inactivation: A versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Song, Yurong ^a   Gilbert, Debra ^a   O'Sullivan, T Norene ^a   Yang, Chunyu ^b   Pan, Wenqi ^c   Fathalizadeh, Alisan ^d   Lu, Lucy ^a   Haines, Diana C ^e   Martin, Philip L ^e   Van Dyke, Terry ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYTOKERATIN 18; CYTOKERATIN 19; PROTEIN P107; PROTEIN P130;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA; CARCINOMA CELL; CELL TYPE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GENE FUNCTION; GENE INACTIVATION; GENE LOCATION; GENETICALLY ENGINEERED MOUSE STRAIN; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; KERATIN-18; KERATIN-19; MICE; MICE, TRANSGENIC; NEOPLASMS; ORGAN SPECIFICITY; RETINOBLASTOMA PROTEIN;

EID: 84891783286     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080459     Document Type: Article

References (40)

1. Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40: 403-439.
2. Omary MB, Ku NO, Strnad P, Hanada S (2009) Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest 119: 1794-1805.
3. Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129: 705-733.
4. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, et al. (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174: 169-174.
5. Oshima RG, Howe WE, Klier FG, Adamson ED, Shevinsky LH (1983) Intermediate filament protein synthesis in preimplantation murine embryos. Dev Biol 99: 447-455.
6. Brulet P, Babinet C, Kemler R, Jacob F (1980) Monoclonal antibodies against trophectoderm-specific markers during mouse blastocyst formation. Proc Natl Acad Sci USA 77: 4113-4117.
7. Lu H, Hesse M, Peters B, Magin TM (2005) Type II keratins precede type I keratins during early embryonic development. Eur J Cell Biol 84: 709-718.
8. Karantza V (2011) Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30: 127-138.
9. Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2: 103-112.
10. Viatour P, Sage J (2011) Newly identified aspects of tumor suppression by RB. Dis Model Mech 4: 581-585.
11. Knudsen ES, Pajak TF, Qeenan M, McClendon AK, Armon BD, et al. (2012) Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression. Journal of the National Cancer Institute 104: 1825-1836.
12. Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, et al. (2007) Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12: 479-491.
13. Witkiewicz AK, Rivadeneira DB, Ertel A, Kline J, Hyslop T, et al. (2011) Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am J Pathol 179: 1171-1178.
14. Reed CA, Mayhew CN, McClendon AK, Yang X, Witkiewicz A, et al. (2009) RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1. Oncogene 28: 4434-4443.
15. Burkhart DL, Sage J (2008) Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nature Reviews Cancer 8: 671-682.
16. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, et al. (2010) The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120: 4478-4492.
17. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-473.
18. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12: 1599-1609.
19. Dannenberg JH, van Rossum A, Schuijff L, te Riele H (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14: 3051-3064.
20. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, et al. (2000) Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14: 3037-3050.
21. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, et al. (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085-1095.
22. Dyson N, Buchkovich K, Whyte P, Harlow E (1989) The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255.
23. Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, et al. (1989) An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 58: 257-267.
24. Stubdal H, Zalvide J, Campbell KS, Schweitzer C, Roberts TM, et al. (1997) Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen. Mol Cell Biol 17: 4979-4990.
25. Sullivan CS, Tremblay JD, Fewell SW, Lewis JA, Brodsky JL, et al. (2000) Species-specific elements in the large T-antigen J domain are required for cellular transformation and DNA replication by simian virus 40. Mol Cell Biol 20: 5749-5757.
26. Hill R, Song Y, Cardiff RD, Van Dyke T (2005) Heterogeneous tumor evolution initiated by loss of pRb function in a preclinical prostate cancer model. Cancer Res 65: 10243-10254.
27. Simin K, Wu H, Lu L, Pinkel D, Albertson D, et al. (2004) pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol 2: E22.
28. Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, et al. (2012) Perturbation of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer. Cancer Res 72: 13.
29. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, et al. (1994) p53- dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.
30. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T (2002) Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1: 157-168.
31. Simin K, Hill R, Song Y, Zhang Q, Bash R, et al. (2005) Deciphering cancer complexities in genetically engineered mice. Cold Spring Harb Symp Quant Biol 70: 283-290.
32. Chen J, Tobin GJ, Pipas JM, Van Dyke T (1992) T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus. Oncogene 7: 1167-1175.
33. Song Y, Zhang Q, Kutlu B, Difilippantonio S, Bash R, et al. (2013) Evolutionary etiology of high-grade astrocytomas. Proc Natl Acad Sci USA 2013; published ahead of print October 10, 2013.
34. Kumar P, Mukherjee M, Johnson JP, Patel M, Huey B, et al. (2012) Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution. PLoS Genet 8: e1003027.
35. Pipas JM, Peden KW, Nathans D (1983) Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the Tantigen gene. Mol Cell Biol 3: 203-213.
36. Sullivan CS, Pipas JM (2002) T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 66: 179-202.
37. Copeland NG, Jenkins NA, Court DL (2001) Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769-779.
38. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, et al. (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73: 56-65.
39. Yan C, Costa RH, Darnell JE, Jr., Chen JD, Van Dyke TA (1990) Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 9: 869-878.
40. Means AL, Xu Y, Zhao A, Ray KC, Gu G (2008) A CK19CreERT knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs. Genesis 46: 318-323.